RxSight outlines $30M-$40M Alcon revenue recognition in 2026 while withdrawing full-year guidance

EarningsNegative

AI Analysis

Summary

RxSight provided 2026 revenue guidance of $30M-$40M from Alcon while withdrawing full-year guidance, signaling uncertainty regarding broader financial performance.

Financial Highlights

Revenue

$30M-$40M

Guidance

withdrawn

Importance:4/10

Sentiment:

-0.40

guidance withdrawalrevenue guidanceAlcon partnershipfinancial update

Read the original article

Published by Seeking Alpha Healthcare on August 6, 2026 6:10 AM

Read Original